安德利(603031.SH):2021年度預虧3900萬元-4400萬元
格隆匯1月26日丨安德利(603031.SH)公佈2021年度業績預虧公吿,公司預計2021年年度歸屬於上市公司股東淨利潤為-3900萬元到-4400萬元。公司預計2021年年度歸屬於上市公司股東扣除非經常性損益的淨利潤為萬元到-4300萬元到-4800萬元。
業績預虧的主要原因:2021年度新增門店7家,主營業務收入同比下降約5%;人力成本增長較大,主要是員工人數的增加,同時員工人均成本也較上年度增加;2021年度公司實施重大資產重組,增加了中介機構費用等重組成本,增加費用約2200萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.